Evaluation of the congenital hypothyroidism screening programme in Iran: a 3-year retrospective cohort study
- 14 March 2018
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 104 (2) , F176-F181
Abstract
Objective To evaluate the newborn screening programme for congenital hypothyroidism (CH) in Iran from diagnosis to management and follow-up for 3 years from 2011 to 2014. Design Retrospective cohort. Setting and patients Seventeen university districts were randomly selected from 30 provinces. Central data in each district were gathered and collectively analysed. Congenital hypothyroid subjects were followed for 3 years. Main outcome measures Programme coverage, screening and treatment age, recall rate, compliance to follow-ups. Results The total number of births in 2011 was 501 726, of which 452 918 neonates (90.3%) were screened and 15 671 (3.46%) were recalled; 1085 (1:462, 0.22%) were confirmed as having CH (57.1%: permanent, 42.9%: transient) and followed for 3 years. Positive predictive value (PPV) for the first screening test was 6.9%. After the second screening, recall rate was reduced to 0.69% and PPV increased to 31.3%. Median age at screening was 6 (3–9) days and for 90.6% of patients treatment was initiated before 40 days of age with a median levothyroxine dosage of 25 µg/day; 131 (13.4%) were lost to follow-up. Mean number of follow-up visits over 3 years was 5.7 (95% CI 5.5 to 5.9) and 23% (n=225) had total compliance to all follow-ups. Median time for thyroid stimulating hormone normalisation was 45 days, 95% CI (41.1 to 48.8). Conclusion In Iran, despite well-established protocols of screening and detecting CH subjects, stricter implementation of a structured system for monitoring and surveillance is needed to promote the management of patients and to reduce rates of loss to follow-up. Determining and addressing the causes of high false positive rates must be prioritised.Keywords
This publication has 29 references indexed in Scilit:
- Growth Hormone/Insulin-Like Growth Factor-1 Axis as Related to Body Mass Index in Patients with Idiopathic Short StatureJournal of Clinical Research in Pediatric Endocrinology, 2013
- Congenital hypothyroidism: managing the hinterland between fact and theoryArchives of Disease in Childhood, 2010
- Treating patients not numbers: the benefit and burden of lowering TSH newborn screening cut-offsArchives of Disease in Childhood, 2010
- Effect of high versus low initial doses of L-thyroxine for congenital hypothyroidism on thyroid function and somatic growthArchives of Disease in Childhood, 2008
- Influence of Timing and Dose of Thyroid Hormone Replacement on Mental, Psychomotor, and Behavioral Development in Children with Congenital HypothyroidismThe Journal of Pediatrics, 2005
- Neurodevelopmental Outcomes in Congenital Hypothyroidism: Comparison of Initial T4 Dose and Time to Reach Target T4 and TSHThe Journal of Pediatrics, 2005
- In search of the optimal therapy for congenital hypothyroidismThe Journal of Pediatrics, 2004
- Coverage of neonatal screening: failure of coverage or failure of information systemArchives of Disease in Childhood, 2001
- Outcome of severe congenital hypothyroidism: closing the developmental gap with early high dose levothyroxine treatmentThe Journal of Clinical Endocrinology & Metabolism, 1996
- Long-term effects of L-thyroxine therapy for congenital hypothyroidismThe Journal of Pediatrics, 1995